Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 688-332-8 | CAS number: 199119-58-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 21 July 1997 to 8 October 1997
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was performed to GLP and in line with standardised guidelines OECD 471, EU Method B.14 and EPA OPPTS 798.5265 with no deviations thought to impact on the reliability of the presented results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5265 (The Salmonella typhimurium Bacterial Reverse Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: MITI (The Ministry of International Trade and Industry), Japan 62 Notification of Basic Industries Bureau No. 1014
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- sodium 4,6-dimethoxy-N-({[3-(2,2,2-trifluoroethoxy)pyridin-2-yl]sulfonyl}carbamoyl)pyrimidin-2-aminide
- EC Number:
- 688-332-8
- Cas Number:
- 199119-58-9
- Molecular formula:
- C14H13F3N5O6SNa
- IUPAC Name:
- sodium 4,6-dimethoxy-N-({[3-(2,2,2-trifluoroethoxy)pyridin-2-yl]sulfonyl}carbamoyl)pyrimidin-2-aminide
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Physical state: solid (powder)
- Stability under test conditions: Stable
- Storage condition of test material: room temperature
Constituent 1
Method
- Target gene:
- S. typhimurium: Histidine synthesis
E. coli: Tryptophan synthesis
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Nutrient broth medium
- Periodically checked for genotype stability: Yes. Histidine auxotrophy was demonstrated by the requirement for L-histidine. The presence of the rfa character was assayed by the sensitivity for crystal violet. The deletion of the uvrB gene was demonstrated by the sensitivity for UV-light. TA 98 and TA 100 containing the R-factor were additionally checked for ampicillin resistance.
- Periodically "cleansed" against high spontaneous background: Yes. All strains were tested for amino acid requirement. - Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- S. typhimurium TA 102
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Nutrient broth medium
- Periodically checked for genotype stability: Yes. Histidine auxotrophy was demonstrated by the requirement for L-histidine. The presence of the rfa character was assayed by the sensitivity for crystal violet. The deletion of the uvrB gene was demonstrated by the sensitivity for UV-light.
- Periodically "cleansed" against high spontaneous background: Yes. All strains were tested for amino acid requirement. - Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Nutrient broth medium
- Periodically checked for genotype stability: Yes. Tryptophan auxotrophy was demonstrated by the requirement for tryptophan. The absence of the uvrA gene was demonstrated by the sensitivity of the strain for UV-light.
- Periodically "cleansed" against high spontaneous background: Yes. All strains were tested for amino acid requirement. - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix
- Test concentrations with justification for top dose:
- 0.08, 0.25, 0.76, 2.29, 6.86 µg/plate (S. typhimurium) both in the presence and absence of metabolic activation
61.73, 185.19, 555.56, 1666.67, 5000.0 µg/plate (E. coli WP2uvrA) both in the presence and absence of metabolic activation
1st confirmatory assays: as above
2nd confirmatory assays:
- TA 1535: 0.76, 2.29, 6.86, 20.57, 61.70 µg/plate both in the presence and absence of metabolic activation
- TA 102: 0.01, 0.03, 0.09, 0.25, 0.76 µg/plate both in the presence and absence of metabolic activation
- TA 98: 0.76, 2.29, 6.86, 20.57, 61.70 µg/plate in the absence of metabolic activation - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- cyclophosphamide
- mitomycin C
- other: 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar - plate incorporation (original experiment)
- preincubation assay (first and second confirmatory experiments)
DURATION
- Exposure duration: Plates were incubated inverted at 37 °C for 48 hours in the dark (plate incorporation). Plates were incubated at 37 ºC for 30 minutes (preincubation assay)
NUMBER OF REPLICATIONS: Test concentrations were performed in triplicate
- EVALUATION PROCEDURE: Following the total incubation period the plates were examined for evidence that the test was valid: i.e. there was a background lawn on the solvent control plates and that the positive controls had responded as expected. All plates were counted using an electronic colony counter. - Evaluation criteria:
- Test data from individual experiments are considered valid if:
a) the concurrent solvent control data are acceptable
b) the positive control data show acceptable increases
A positive response in a (valid) individual experiment is achieved when one or both of the following are met:
a) at least a reproducible doubling of the mean number of revertants per plate above that of the solvent control at any concentration for one or more of the following strains: TA 98, TA 1535, TA 1537, E coli WP2 uvrA ;
b) a reproducible increase of the mean number of revertants per plate for any concentration above that of the negative control be at least a factor of 1.5 for strains TA 100 or TA102.
Generally a concentration-related effect should be demonstrable. - Statistics:
- Statistical analyses were not performed.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- The test material was found to have a growth inhibiting effect.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- The test material was found to have a growth inhibiting effect.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: The test compound did not precipitate at and concentration tested.
RANGE-FINDING/SCREENING STUDIES:
A range finding test was carried out with strains S. Typhimurium TA 100 and E. Coli WP2 uvrA with and without metabolic activation at six concentrations of the test material and one solvent control. The highest concentration applied was 5000.0 µg/plate. The five lower concentrations decreased by a factor of three. The plates were inverted and incubated for about 48 hours at 37 ± 12.5 ºC in darkness. Thereafter, they were evaluated by counting the colonies and determining the background lawn. One plate per test material concentration and solvent control was used.However, since considerable growth inhibiting effects of the test material were seen in strain TA 100, an additional experiment with this strain with and without metabolic activation was performed using concentrations of 0.08 – 20.6 µg/plate. No background growth was observed with strain TA 100 at the concentrations of 20.6 to 5000.0 µg/plate. The numbers of revertant colonies were reduced at the concentrations of 6.87 to 5000.0 µg/plate. From the results obtained, the highest concentration suitable for the mutagenicity test was selected to be 5000.0 µg/plate (E. Coli WP2 uvrA) and 6.86 µg/plate (S. Typhimurium) with and without metabolic activation.
COMPARISON WITH HISTORICAL CONTROL DATA:
The results of the study were found to be comparable with the historical control.
ADDITIONAL INFORMATION ON CYTOTOXICITY: Due to a growth inhibiting effect, no background lawn could be observed in the experiments with metabolic activation on strain TA 100 (6.86 µg/plate), TA 1535 (61.7 µg/plate) and TA 102 (2.29 and 6.86 µg/plate). In the experimetns without activation the background lawn was invisible on strains TA 1535 (61.7 µg/plate) and TA 102 (2.29 and 6.86 µg/plate). Also the number of revertant colonies was reduced int he experiments with metabolic activation on strains TA 100, TA 98, TA 1537 (6.86 µg/plate), TA 1535 (20.57 and 61.7 µg/plate) and TA 102 (0.76 to 6.86 µg/plate). In the experiment without metabolic activation a reduction in the number of revertant colonies occurres on strains TA 100 (6.86 µg/plate), TA 1535 (20.57 and 61.7 µg/plate), TA 102 (0.76 to 6.86 µg/plate), TA 98 (61.7 µg/plate), TA 1537 (2.29 and 6.86 µg/plate) and E.coli WP2uvrA (5000.0 µg/plate).
Any other information on results incl. tables
Table 2: Summary of Original Mutagenicity Experiment
Strain |
Treatment |
Mean counts (+ S9) |
Mean counts (-S9) |
TA 100 |
solvent control |
108.33 |
100.67 |
0.08 µg/plate |
102.33 |
100.00 |
|
0.25 µg/plate |
112.33 |
90.00 |
|
0.76 µg/plate |
101.67 |
94.00 |
|
2.29 µg/plate |
99.67 |
77.67 |
|
6.86 µg/plate |
19.33 |
15.67 |
|
positive control |
1491.67 |
1097.67 |
|
WP2 uvrA |
solvent control |
21.67 |
16.33 |
61.73 µg/plate |
17.67 |
18.67 |
|
185.19 µg/plate |
21.00 |
19.00 |
|
555.56 µg/plate |
20.67 |
17.67 |
|
1666.67 µg/plate |
18.33 |
18.33 |
|
5000.0 µg/plate |
17.33 |
17.67 |
|
positive control |
1077.67 |
605.67 |
|
TA 1537 |
solvent control |
7.67 |
6.00 |
0.08 µg/plate |
8.67 |
6.33 |
|
0.25 µg/plate |
7.33 |
5.67 |
|
0.76 µg/plate |
8.33 |
6.67 |
|
2.29 µg/plate |
4.33 |
3.00 |
|
6.86 µg/plate |
3.67 |
1.67 |
|
positive control |
200.67 |
1349.67 |
|
TA 1535 |
solvent control |
18.33 |
12.00 |
0.08 µg/plate |
17.00 |
10.00 |
|
0.25 µg/plate |
15.00 |
14.00 |
|
0.76 µg/plate |
14.00 |
13.33 |
|
2.29 µg/plate |
14.67 |
10.67 |
|
6.86 µg/plate |
15.00 |
8.33 |
|
positive control |
344.00 |
699.33 |
|
TA 98 |
solvent control |
37.33 |
29.67 |
0.08 µg/plate |
37.33 |
25.33 |
|
0.25 µg/plate |
37.33 |
24.67 |
|
0.76 µg/plate |
39.67 |
29.67 |
|
2.29 µg/plate |
34.67 |
27.00 |
|
6.86 µg/plate |
33.67 |
21.33 |
|
positive control |
755.67 |
297.67 |
|
TA 102 |
solvent control |
252.33 |
253.67 |
0.08 µg/plate |
229.00 |
239.00 |
|
0.25 µg/plate |
182.67 |
168.67 |
|
0.76 µg/plate |
61.67 |
15.67 |
|
2.29 µg/plate |
1.33 |
10.00 |
|
6.86 µg/plate |
0.00 |
1.33 |
|
positive control |
2358.33 |
1083.00 |
Table 3: Summary of 1st Confirmatory Experiment
Strain |
Treatment |
Mean counts (+ S9) |
Mean counts (-S9) |
TA 100 |
solvent control |
136.33 |
136.00 |
0.08 µg/plate |
135.33 |
158.00 |
|
0.25 µg/plate |
162.00 |
143.00 |
|
0.76 µg/plate |
97.00 |
164.33 |
|
2.29 µg/plate |
138.00 |
149.33 |
|
6.86 µg/plate |
0.00 |
156.67 |
|
positive control |
1505.33 |
1158.00 |
|
WP2 uvrA |
solvent control |
24.00 |
26.33 |
61.73 µg/plate |
19.00 |
16.33 |
|
185.19 µg/plate |
17.33 |
15.33 |
|
555.56 µg/plate |
17.67 |
21.33 |
|
1666.67 µg/plate |
19.67 |
18.33 |
|
5000.0 µg/plate |
20.67 |
11.33 |
|
positive control |
495.00 |
447.67 |
|
TA 1537 |
solvent control |
10.33 |
11.33 |
0.08 µg/plate |
8.33 |
8.00 |
|
0.25 µg/plate |
8.67 |
7.67 |
|
0.76 µg/plate |
8.67 |
7.00 |
|
2.29 µg/plate |
13.67 |
6.67 |
|
6.86 µg/plate |
2.33 |
7.00 |
|
positive control |
269.67 |
1109.00 |
|
TA 1535 |
solvent control |
14.33 |
15.33 |
0.08 µg/plate |
16.67 |
18.67 |
|
0.25 µg/plate |
16.00 |
16.67 |
|
0.76 µg/plate |
22.67 |
16.00 |
|
2.29 µg/plate |
19.67 |
18.67 |
|
6.86 µg/plate |
10.00 |
19.33 |
|
positive control |
413.33 |
765.33 |
|
TA 98 |
solvent control |
29.33 |
18.33 |
0.08 µg/plate |
28.00 |
18.67 |
|
0.25 µg/plate |
29.33 |
16.67 |
|
0.76 µg/plate |
26.33 |
13.00 |
|
2.29 µg/plate |
28.33 |
22.00 |
|
6.86 µg/plate |
14.67 |
14.33 |
|
positive control |
1075.67 |
300.33 |
|
TA 102 |
solvent control |
264.33 |
271.33 |
0.08 µg/plate |
242.00 |
237.33 |
|
0.25 µg/plate |
221.33 |
172.33 |
|
0.76 µg/plate |
110.33 |
74.33 |
|
2.29 µg/plate |
41.00 |
21.00 |
|
6.86 µg/plate |
0.00 |
16.33 |
|
positive control |
1635.00 |
1296.33 |
Table 4: Summary of 2nd Confirmatory Experiment
Strain |
Treatment |
Mean counts (+ S9) |
Mean counts (-S9) |
TA 1535 |
solvent control |
14.67 |
10.00 |
0.76 µg/plate |
12.00 |
12.00 |
|
2.29 µg/plate |
16.00 |
9.33 |
|
6.86 µg/plate |
12.67 |
10.00 |
|
20.57 µg/plate |
5.33 |
3.33 |
|
61.70 µg/plate |
0.00 |
0.00 |
|
positive control |
287.67 |
589.67 |
|
TA 102 |
solvent control |
339.67 |
306.33 |
0.01 µg/plate |
330.33 |
275.00 |
|
0.03 µg/plate |
318.00 |
275.00 |
|
0.09 µg/plate |
243.33 |
214.33 |
|
0.25 µg/plate |
227.33 |
177.67 |
|
0.76 µg/plate |
96.33 |
32.00 |
|
positive control |
978.00 |
1220.67 |
|
TA 98 |
solvent control |
12.00 |
|
0.76 µg/plate |
16.67 |
||
2.29 µg/plate |
13.33 |
||
6.86 µg/plate |
6.67 |
||
20.57 µg/plate |
8.00 |
||
61.70 µg/plate |
2.00 |
||
positive control |
275.67 |
Applicant's summary and conclusion
- Conclusions:
- Under the specific conditions of this assay, the test material gave a negative (i.e. non-mutagenic), response in Salmonella typhimurium strains TA 1535, TA 1537, TA 98 , TA 100 and TA 102 and E. coli strain WP2 uvrA both in the presence and absence of metabolic activation. The study is considered to be reliable, relevant and adequate for risk assessment and classification and labelling purposes.
- Executive summary:
The potential of the test material to cause gene mutation in bacterial strains was determined in accordance with standardised guidelines OECD 471, EU Method B.14 and EPA OPPTS 798.5265. Five strains of Salmonella typhimurium (TA 1535, TA 1537, TA 98, TA 100 and TA 102) and one Escherichia coli strain (WP2uvrA) were treated in the presence and absence of a rat liver derived metabolic activation system (S9 mix). The first confirmatory experiment was carried out with and without metabolic activation. Since marked differences in toxicity occurred with the strains used, a second confirmatory experiment was performed with and without metabolic activation on strains TA 1535 and TA 102. Strain TA 98 was tested without activation. Each strain was additionally tested in the presence and in the absence of a metabolic activation system with a suitable, known mutagen as positive control.
The original experiment with and without metabolic activation and the confirmatory experiment without activation were performed as standard plate incorporation assay. The first and second confirmatory experiments with metabolic activation were carried out as preincubation assay.
In both experiments, performed with and without metabolic activation, none of the tested concentrations of test material led to an increase in the incidence of either histidine- or tryptophan-prototrophic mutants by comparison with the solvent control.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
